Literature DB >> 19633429

Targeting bioenergetics to enhance cancer chemotherapy: mitochondria SLP into apoptosis.

Shikha Khatri1, David R Plas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19633429      PMCID： PMC2903429          DOI： 10.4161/cbt.8.17.9456

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  22 in total

1.  OPA1 alternate splicing uncouples an evolutionary conserved function in mitochondrial fusion from a vertebrate restricted function in apoptosis.

Authors:  A Olichon; G Elachouri; L Baricault; C Delettre; P Belenguer; G Lenaers
Journal:  Cell Death Differ       Date:  2006-10-06       Impact factor: 15.828

2.  A chemical inhibitor of DRP1 uncouples mitochondrial fission and apoptosis.

Authors:  Atsushi Tanaka; Richard J Youle
Journal:  Mol Cell       Date:  2008-02-29       Impact factor: 17.970

Review 3.  Mitochondrial dynamics and apoptosis.

Authors:  Der-Fen Suen; Kristi L Norris; Richard J Youle
Journal:  Genes Dev       Date:  2008-06-15       Impact factor: 11.361

4.  ATP citrate lyase inhibition can suppress tumor cell growth.

Authors:  Georgia Hatzivassiliou; Fangping Zhao; Daniel E Bauer; Charalambos Andreadis; Anthony N Shaw; Dashyant Dhanak; Sunil R Hingorani; David A Tuveson; Craig B Thompson
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

5.  Activated mitofusin 2 signals mitochondrial fusion, interferes with Bax activation, and reduces susceptibility to radical induced depolarization.

Authors:  Margaret Neuspiel; Rodolfo Zunino; Sandhya Gangaraju; Peter Rippstein; Heidi McBride
Journal:  J Biol Chem       Date:  2005-05-04       Impact factor: 5.157

6.  Identification of a novel mitochondrial complex containing mitofusin 2 and stomatin-like protein 2.

Authors:  Petr Hájek; Anne Chomyn; Giuseppe Attardi
Journal:  J Biol Chem       Date:  2006-11-22       Impact factor: 5.157

7.  Opa1-mediated cristae opening is Bax/Bak and BH3 dependent, required for apoptosis, and independent of Bak oligomerization.

Authors:  Ryuji Yamaguchi; Lydia Lartigue; Guy Perkins; Ray T Scott; Amruta Dixit; Yulia Kushnareva; Tomomi Kuwana; Mark H Ellisman; Donald D Newmeyer
Journal:  Mol Cell       Date:  2008-08-07       Impact factor: 17.970

8.  Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis.

Authors:  Ralph J DeBerardinis; Anthony Mancuso; Evgueni Daikhin; Ilana Nissim; Marc Yudkoff; Suzanne Wehrli; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-21       Impact factor: 11.205

9.  SLP-2 interacts with prohibitins in the mitochondrial inner membrane and contributes to their stability.

Authors:  Sandrine Da Cruz; Philippe A Parone; Philippe Gonzalo; Willy V Bienvenut; Daniel Tondera; Alexis Jourdain; Manfredo Quadroni; Jean-Claude Martinou
Journal:  Biochim Biophys Acta       Date:  2008-02-20

10.  OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion.

Authors:  Christian Frezza; Sara Cipolat; Olga Martins de Brito; Massimo Micaroni; Galina V Beznoussenko; Tomasz Rudka; Davide Bartoli; Roman S Polishuck; Nika N Danial; Bart De Strooper; Luca Scorrano
Journal:  Cell       Date:  2006-07-14       Impact factor: 41.582
View more
  1 in total

1.  OPA1 downregulation is involved in sorafenib-induced apoptosis in hepatocellular carcinoma.

Authors:  Xiangxuan Zhao; Changhai Tian; William M Puszyk; Olorunseun O Ogunwobi; Mengde Cao; Ton Wang; Roniel Cabrera; David R Nelson; Chen Liu
Journal:  Lab Invest       Date:  2012-10-29       Impact factor: 5.662
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.